Keros Therapeutics Inc (NASDAQ:KROS) Drops -2.18%, But Further Rally Could Be Imminent
In last trading session, Keros Therapeutics Inc (NASDAQ:KROS) saw 0.4 million shares changing hands with its beta currently measuring 1.16. Company’s recent per share price